Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 3/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 5/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CRHBP | P24387 | 1/20 | 0.36 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL8313123 | 1.00 | CYP1A1 (0.40) | CYP1A1CYP1B1CYP1A2CYP2D6ABCG2 | |
| Oxalic Acid SCHEMBL8315178 | 0.86 | PTGS2 (0.39) | CYP1A1CYP1B1CYP1A2CYP2D6CYP3A4 | |
| Oxalic Acid SCHEMBL8315183 | 0.86 | PTGS2 (0.39) | CYP1A1CYP1B1CYP1A2CYP2D6CYP3A4 | |
| SCHEMBL8311619 | 0.85 | MAPT (0.44) | CYP1A1CYP1B1CYP1A2TP53SMN1; SMN2 | |
| SCHEMBL8311200 | 0.85 | MAPT (0.44) | CYP1A1CYP1B1CYP1A2TP53SMN1; SMN2 | |
| SCHEMBL8313159 | 0.81 | MAPT (0.45) | CYP1A1CYP1B1CYP1A2TP53SMN1; SMN2 | |
| SCHEMBL8313155 | 0.81 | MAPT (0.45) | CYP1A1CYP1B1CYP1A2TP53SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL8454360 | 0.81 | MAPT (0.47) | CYP1A1CYP1B1CYP1A2TP53SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL8454357 | 0.81 | MAPT (0.47) | CYP1A1CYP1B1CYP1A2TP53SMN1; SMN2 | |
| SCHEMBL8316370 | 0.79 | PTGS2 (0.41) | CYP1A1CYP1B1CYP1A2CYP2D6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0351856-B1 | Thiazolo[5,4-b]azepine compounds | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1999-09-15 | — | — | EP | disclosed |
| US-5300639-A | 2-oxo-3-carbonylamino-substituted azepine intermediates; lipoperoxide formation inhibitors | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-04-05 | — | — | US | disclosed |
| US-5118806-A | Enzyme inhibitor for lipoxygenase; useful for treating cancer, hepatic diseases, inflammation, cerebrovascular diseases | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-06-02 | — | — | US | disclosed |